专题：Lung Cancer Research Studies

This cluster of papers represents a comprehensive exploration of small cell lung cancer, covering topics such as genomic profiles, immunotherapy, chemotherapy, prognostic factors, biomarkers, targeted therapy, clinical trials, metastasis, and tumor markers.
最新文献
Advances in molecular pathology and therapy of non-small cell lung cancer

review Full Text OpenAlex

CRAMP1-dependent histone H1 biogenesis is essential for topoisomerase II inhibitor tolerance

article Full Text OpenAlex

Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?

letter Full Text OpenAlex

Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE

erratum Full Text OpenAlex

Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report

article Full Text OpenAlex

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

article Full Text OpenAlex

Low expression of CADPS predicts poor prognosis in pediatric acute lymphoblastic leukemia without fusion genes

article Full Text OpenAlex

TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study

article Full Text OpenAlex

Sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated locally advanced or metastatic (LA/M) non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: Preliminary results from a phase 2 study.

article Full Text OpenAlex

ZL-1310, a DLL3 ADC, in patients with extensive stage small cell lung cancer: Ph1 trial update.

article Full Text OpenAlex

近5年高被引文献
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

review Full Text OpenAlex 2909 FWCI94.126

Lung cancer

review Full Text OpenAlex 1751 FWCI68.479

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 1119 FWCI221.122

Small-cell lung cancer

review Full Text OpenAlex 1071 FWCI32.325

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

review Full Text OpenAlex 983 FWCI37.532

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

article Full Text OpenAlex 726 FWCI62.423

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

article Full Text OpenAlex 616 FWCI213.477

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

article Full Text OpenAlex 613 FWCI51.512

Lung cancer immunotherapy: progress, pitfalls, and promises

review Full Text OpenAlex 607 FWCI46

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

review Full Text OpenAlex 607 FWCI33.149